• Select qualified patients that meet the Quality Oncology Practice Initiative (QOPI®) case selection method,
• Apply chemotherapy order safety principles based on a patient case scenario, and
• Generate an ASCO treatment plan and summary report.

“We are pleased to again be selected to show our oncology specific functionality to this year’s ASCO EHR lab attendees,” says Dave Eggert, Medical Oncology Business Marketing Manager for Impac Software. “With all of the buzz surrounding EMR implementation as part of the stimulus package, it’s even more important to make an informed decision about an EMR choice.”

The EHR Lab will be located on the exhibit hall floor within the Orange County Convention Center during the following hours:

• Saturday, May 30, 2009, 9 a.m. - 5 p.m.
• Sunday, May 31, 2009, 9 a.m. - 5 p.m.
• Monday, June 1, 2009, 9 a.m. - 5 p.m.

For additional information regarding ASCOs EHR Lab, visit: http://www.asco.org/ehr. For full details and a demonstration of MOSAIQ, visit Impac Software booth #3401 at ASCO.

About Impac Software
Impac Software, part of the Elekta Group, provides software solutions that streamline clinical and business operations across the spectrum of cancer care. Impac Software’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as systems for anatomic pathology, clinical laboratory and cancer registry.

With products that cover diagnosis and treatment through long-term follow-up, Impac Software provides a comprehensive oncology management solution that helps improve overall communication, process efficiency and quality patient care.

Impac Software is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders. With more than 2,500 employees globally, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at impac.com and elekta.com.